Answers are grounded in this paper and cite their sources.
Rabies encephalitis remains an almost invariably fatal viral infection once clinical neuro-invasion is established. Current post-exposure prophylaxis (PEP) fails to neutralize the virus once it has passed the Blood-Brain Barrier (BBB). Here, we present the rational computational design of CRM-101, a modular, bispecific lipopeptidomimetic construct engineered for both BBB transcytosis and high-affinity neutralization of the canonical Antigenic Site III on the rabies virus glycoprotein (RABV-G). The construct comprises: (1) a constrained heptapeptide warhead (CRM-101A: Ac-cyclo[Cys1-Cys7] CDFEYWC-NH2), (2) a steric-decoupling octaethylene glycol spacer (PEG8, ~25.6 Å contour length), (3) a lipophilic half-life extender (N-epsilon-palmitoyl-L-lysine albumin-binding tag), and (4) a protease-resistant transcytosis shuttle (D-Retro-Inverso RVG29 with a methionine-to-norleucine substitution: GNSARKGRSNTFIDCPTGPRPNEP[Nle]WITY-NH2). In all-atom explicit-solvent molecular dynamics pilot simulations (310 K), the warhead remained firmly bound to the canonical KSVRTWNE motif of RABV-G (mean contact distance: 2.77 ± 0.13 Å), establishing persistent hydrogen bonds with Ser289 (2.83 Å) and Glu295 (2.96 Å), alongside salt bridges with Arg291 (3.29 Å) and Lys288 (3.66 Å). While raw implicit-solvent MM-GBSA enthalpy yielded -27.67 kcal/mol, incorporation of the estimated conformational entropic penalty (-TΔS ≈ +17.5 kcal/mol) calibrates the net binding free energy (ΔG_bind) to -10.17 kcal/mol, predicting a physically plausible nanomolar affinity (Kd ~ 68 nM). Physiologically based pharmacokinetic (PBPK) ODE modeling in mice (10 mg/kg i.v.) incorporating active renal filtration and parenchymal clearance revealed a peak brain concentration (Cmax) of 54.44 nM at 8.4 hours, remaining above the 20 nM IC50 threshold for 31.2 consecutive hours (30.90 nM at 24 hours) before clearing to 9.00 nM at 48 hours. In tandem, active-site docking of Favipiravir-RTP against the Rabies RdRp catalytic pocket (PDB: 6UEB) showed bidentate coordination to catalytic Mg2+ ions and an estimated ΔG of -27.80 kcal/mol. These computational findings support immediate wet-lab solid-phase synthesis and surface plasmon resonance (SPR) validation of the core neutralizing fragment (CRM-101A). • Project Lead & Conception: Radu-Mihai Clinciu (Independent Project Originator, Romania; Contact: radumihaiclinciu@yahoo.com).• Computational Workflow: Designed and validated using an automated biocomputing toolchain (OpenMM, MDTraj, RDKit, AutoDock Vina, Typst). All raw scripts, 3D coordinates, and validation protocols are provided in the accompanying open-access research package.
No takes yet. Share an insight, caveat, or question.
Radu-Mihai Clinciu (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: